Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Genotyping of Italian patients with Behçet syndrome identified two novel ERAP1 polymorphisms using sequencing-based approach.

Padula MC, Leccese P, Lascaro N, Carbone T, Gilio M, Padula AA, Martelli G, D'Angelo S.

Hum Immunol. 2019 Feb 8. pii: S0198-8859(18)30941-8. doi: 10.1016/j.humimm.2019.02.003. [Epub ahead of print]

PMID:
30742879
2.

Brain glucose consumption abnormalities in neuro-Behçet's disease: a preliminary 18F-FDG PET/CT study.

D'Angelo S, Chiaravalloti A, Ursini F, Barbagallo G, Gilio M, Leccese P, De Giorgio R, Di Giorgio E, Schillaci O.

Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):148-149. Epub 2018 Dec 14. No abstract available.

3.

Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis.

Felice C, Leccese P, Scudeller L, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Olivieri I, Armuzzi A; Italian SpA-IBD Expert Panel Group.

Clin Exp Immunol. 2018 Dec 15. doi: 10.1111/cei.13246. [Epub ahead of print]

PMID:
30554407
4.

Management of major organ involvement of Behçet's syndrome: a systematic review for update of the EULAR recommendations.

Ozguler Y, Leccese P, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Çelik AF, Fortune F, Gaudric J, Gul A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Rheumatology (Oxford). 2018 Dec 1;57(12):2200-2212. doi: 10.1093/rheumatology/key242.

PMID:
30107448
5.

New Insights into Behçet's Syndrome Metabolic Reprogramming: Citrate Pathway Dysregulation.

Santarsiero A, Leccese P, Convertini P, Padula A, Abriola P, D'Angelo S, Bisaccia F, Infantino V.

Mediators Inflamm. 2018 Jun 28;2018:1419352. doi: 10.1155/2018/1419352. eCollection 2018.

6.

Standardization of red flags for referral to rheumatologists and ophthalmologists in patients with rheumatic diseases and ocular involvement: a consensus statement.

Olivieri I, Accorinti M, Abicca I, Bisceglia P, Cimino L, Latanza L, Leccese P, Lubrano E, Marchesoni A, Miserocchi E, Neri P, Salvarani C, Scarpa R, D'Angelo S; CORE Study Group.

Rheumatol Int. 2018 Sep;38(9):1727-1734. doi: 10.1007/s00296-018-4094-1. Epub 2018 Jun 30.

PMID:
29961101
7.

Management of skin, mucosa and joint involvement of Behçet's syndrome: A systematic review for update of the EULAR recommendations for the management of Behçet's syndrome.

Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gül A, Kötter I, Mahr A, Moots RJ, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H, Hatemi G.

Semin Arthritis Rheum. 2018 May 19. pii: S0049-0172(18)30240-3. doi: 10.1016/j.semarthrit.2018.05.008. [Epub ahead of print]

PMID:
29954598
8.

2018 update of the EULAR recommendations for the management of Behçet's syndrome.

Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F, Gaudric J, Gul A, Kötter I, Leccese P, Mahr A, Moots R, Ozguler Y, Richter J, Saadoun D, Salvarani C, Scuderi F, Sfikakis PP, Siva A, Stanford M, Tugal-Tutkun I, West R, Yurdakul S, Olivieri I, Yazici H.

Ann Rheum Dis. 2018 Jun;77(6):808-818. doi: 10.1136/annrheumdis-2018-213225. Epub 2018 Apr 6.

PMID:
29625968
9.

ERAP1 molecular characterization: Identification of a de novo allelic variant.

Padula MC, Leccese P, Padula AA, D'Angelo S, Martelli G.

HLA. 2018 Mar 26. doi: 10.1111/tan.13262. [Epub ahead of print]

PMID:
29577660
10.

Safety of treatment options for spondyloarthritis: a narrative review.

D'Angelo S, Carriero A, Gilio M, Ursini F, Leccese P, Palazzi C.

Expert Opin Drug Saf. 2018 May;17(5):475-486. doi: 10.1080/14740338.2018.1448785. Epub 2018 Mar 14. Review.

PMID:
29505325
11.

Pure red aplasia induced by sodium valproate in a patient with Behçet's syndrome.

Leccese P, Attolico I, Padula A, Diplomatico A, D'Angelo S, Olivieri I.

Clin Exp Rheumatol. 2017 Nov-Dec;35 Suppl 108(6):132. Epub 2017 Oct 27. No abstract available.

PMID:
29148419
12.

Vitamin D deficiency in systemic sclerosis: a possible role of subclinical liver fibrosis? Retrospective analysis from an Italian cohort.

Ursini F, D'Angelo S, Padula A, Leccese P, Abignano G, Mennillo GA, Ammerata G, De Sarro G, Olivieri I.

Clin Rheumatol. 2017 Dec;36(12):2871-2872. doi: 10.1007/s10067-017-3709-3. Epub 2017 Jun 3. No abstract available.

PMID:
28578491
13.

Review of the treatment of psoriatic arthritis with biological agents: choice of drug for initial therapy and switch therapy for non-responders.

D'Angelo S, Tramontano G, Gilio M, Leccese P, Olivieri I.

Open Access Rheumatol. 2017 Mar 2;9:21-28. doi: 10.2147/OARRR.S56073. eCollection 2017. Review.

14.

Golimumab for the treatment of axial spondyloarthritis.

Palazzi C, D'angelo S, Gilio M, Leccese P, Padula A, Olivieri I.

Expert Opin Biol Ther. 2017 Jan;17(1):129-133. Epub 2016 Nov 9. Review.

PMID:
27817204
15.

Highlights of the 17th International Conference on Behçet's syndrome.

Esatoglu SN, Hatemi G, Leccese P, Olivieri I.

Clin Exp Rheumatol. 2016 Sep-Oct;34(6 Suppl 102):3-9. Epub 2016 Oct 25. No abstract available.

16.

Improvements in diagnostic tools for early detection of psoriatic arthritis.

D'Angelo S, Palazzi C, Gilio M, Leccese P, Padula A, Olivieri I.

Expert Rev Clin Immunol. 2016 Nov;12(11):1209-1215. Epub 2016 Jun 10. Review.

PMID:
27284965
17.

Behcet's syndrome in nonendemic regions.

Leccese P, Yazici Y, Olivieri I.

Curr Opin Rheumatol. 2017 Jan;29(1):12-16. Review.

PMID:
27684358
18.

Intrinsic Connections of the Core Auditory Cortical Regions and Rostral Supratemporal Plane in the Macaque Monkey.

Scott BH, Leccese PA, Saleem KS, Kikuchi Y, Mullarkey MP, Fukushima M, Mishkin M, Saunders RC.

Cereb Cortex. 2017 Jan 1;27(1):809-840. doi: 10.1093/cercor/bhv277.

19.

Pharmacological therapy of spondyloarthritis.

Palazzi C, D'Angelo S, Gilio M, Leccese P, Padula A, Olivieri I.

Expert Opin Pharmacother. 2015;16(10):1495-504. doi: 10.1517/14656566.2015.1052744. Epub 2015 Jun 14. Review.

PMID:
26073668
20.

What do patients want? Survey of patient desires for education in an urban university hospital.

Seibert T, Veazey K, Leccese P, Druck J.

West J Emerg Med. 2014 Nov;15(7):764-9. doi: 10.5811/westjem.2014.9.20674. Epub 2014 Oct 29.

21.

An update on the management of hepatitis C virus-related arthritis.

Palazzi C, D'Amico E, D'Angelo S, Gilio M, Leccese P, Olivieri I.

Expert Opin Pharmacother. 2014 Oct;15(14):2039-45. doi: 10.1517/14656566.2014.946404. Epub 2014 Aug 22. Review.

PMID:
25146875
22.

Adalimumab for treatment of severe Behçet's uveitis: a retrospective long-term follow-up study.

Interlandi E, Leccese P, Olivieri I, Latanza L.

Clin Exp Rheumatol. 2014 Jul-Aug;32(4 Suppl 84):S58-62. Epub 2014 Jul 8.

PMID:
25005224
23.

Safety of anti-tumor necrosis factor agents in psoriatic arthritis - an update.

Palazzi C, D'Angelo S, Leccese P, Padula A, Olivieri I.

Expert Opin Drug Saf. 2014 Feb;13(2):191-6. doi: 10.1517/14740338.2014.857655. Epub 2013 Nov 13. Review.

PMID:
24219428
24.

Spondyloarthritis with onset after age 45.

Olivieri I, D'Angelo S, Padula A, Leccese P, Palazzi C.

Curr Rheumatol Rep. 2013 Dec;15(12):374. doi: 10.1007/s11926-013-0374-7. Review.

PMID:
24170254
25.

High prevalence of Behçet's disease in southern Italy.

Olivieri I, Leccese P, Padula A, Nigro A, Palazzi C, Gilio M, D'Angelo S.

Clin Exp Rheumatol. 2013 May-Jun;31(3 Suppl 77):28-31. Epub 2013 Apr 2.

PMID:
23557837
26.

Anti-TNF agents for the treatment of active non-radiographic axial spondyloarthritis.

Olivieri I, D'Angelo S, Palazzi C, Leccese P, Nigro A, Padula A.

Reumatismo. 2013 Mar 28;65(1):1-3. doi: 10.4081/reumatismo.2013.1. No abstract available.

PMID:
23550255
27.

Ochronotic arthropathy of the spine limited to the thoracic section.

Palazzi C, D'Angelo S, Leccese P, Nigro A, Olivieri I.

Rheumatology (Oxford). 2013 May;52(5):799. doi: 10.1093/rheumatology/kes396. Epub 2013 Jan 7. No abstract available.

PMID:
23300332
28.

Can we reduce the dosage of biologics in spondyloarthritis?

Olivieri I, D'Angelo S, Padula A, Leccese P, Nigro A, Palazzi C.

Autoimmun Rev. 2013 May;12(7):691-3. doi: 10.1016/j.autrev.2012.08.013. Epub 2012 Aug 23. Review.

PMID:
22940233
29.

Late-onset spondyloarthritis: subset that should not be forgotten.

Olivieri I, D'Angelo S, Palazzi C, Leccese P, Padula A.

J Rheumatol. 2012 Jun;39(6):1110-2. doi: 10.3899/jrheum.120184. Epub 2012 May 15. No abstract available.

PMID:
22589252
30.

Low frequency of axial involvement in southern Italian Caucasian children with HLA-B27 positive juvenile onset undifferentiated spondyloarthritis.

Olivieri I, Cutro MS, D'Angelo S, Leccese P, Mennillo GA, Scarano E, Abate R, Palazzi C, Padula A.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):290-6. Epub 2012 Apr 13.

PMID:
22325303
31.

Efficacy of adalimumab in patients with Behçet's disease unsuccessfully treated with infliximab.

Olivieri I, Leccese P, D'Angelo S, Padula A, Nigro A, Palazzi C, Coniglio G, Latanza L.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S54-7. Epub 2011 Sep 27.

PMID:
21968237
32.

Efficacy of switching to adalimumab in a patient with refractory uveitis of Behçet's disease to infliximab.

Leccese P, Latanza L, D'Angelo S, Padula A, Olivieri I.

Clin Exp Rheumatol. 2011 Jul-Aug;29(4 Suppl 67):S93. Epub 2011 Sep 27. No abstract available.

PMID:
21813069
33.

Worsening of psoriasis with rituximab therapy.

Olivieri I, D'Angelo S, Leccese P, Vertone D, Olivieri A.

Clin Exp Rheumatol. 2010 Nov-Dec;28(6):926. Epub 2011 Jan 4. No abstract available.

PMID:
21205468
34.

Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.

Leccese P, D'Angelo S, Angela P, Coniglio G, Olivieri I.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S102. Epub 2010 Sep 24. No abstract available.

PMID:
20868587
35.

Successful treatment of leg ulcers in Behçet's disease using adalimumab plus methotrexate after the failure of infliximab.

Atzeni F, Leccese P, D'Angelo S, Sarzi-Puttini P, Olivieri I.

Clin Exp Rheumatol. 2010 Jul-Aug;28(4 Suppl 60):S94. Epub 2010 Sep 24. No abstract available.

PMID:
20868581
36.

Emerging drugs for psoriatic arthritis.

Olivieri I, D'Angelo S, Palazzi C, Lubrano E, Leccese P.

Expert Opin Emerg Drugs. 2010 Sep;15(3):399-414. doi: 10.1517/14728214.2010.497139. Review.

PMID:
20528612
37.

Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.

Olivieri I, D' Angelo S, Padula A, Leccese P, Mennillo GA.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S112. No abstract available.

PMID:
19796550
38.

Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis.

D'Angelo S, Cutro MS, Lubrano E, Leccese P, Mennillo GA, Ferrara N, Olivieri I.

Ann Rheum Dis. 2010 May;69(5):934-5. doi: 10.1136/ard.2009.119446. Epub 2009 Aug 9. No abstract available.

PMID:
19666936
39.

Long-lasting remission of severe Behçet's disease after the end of infliximab therapy.

Olivieri I, Padula A, Leccese P, D'Angelo S, Giasi V.

J Rheumatol. 2009 Apr;36(4):855. doi: 10.3899/jrheum.081063. No abstract available.

PMID:
19342728
40.

Sensitivity of the classification of psoriatic arthritis criteria in early psoriatic arthritis.

D'Angelo S, Mennillo GA, Cutro MS, Leccese P, Nigro A, Padula A, Olivieri I.

J Rheumatol. 2009 Feb;36(2):368-70. doi: 10.3899/jrheum.080596. Epub 2009 Feb 4.

PMID:
19208566

Supplemental Content

Loading ...
Support Center